Deya Corzo

Deya Corzo

Company: Sigilon Therapeutics

Job title: CMO


Delivering on Hope for Patients with Serious Chronic Diseases 4:30 pm

• Optimization of human allogeneic cells shielded by antifibrotic biomaterials as a new platform for the treatment of chronic diseases, including metabolic disorders • Proof of concept results in animal models of lysosomal diseases • Applicability of platform to metabolic disorders other than LSDsRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.